Citation: H. Wanebo et al., TOTAL THYROIDECTOMY DOES NOT ENHANCE DISEASE-CONTROL OR SURVIVAL EVENIN HIGH-RISK PATIENTS WITH DIFFERENTIATED THYROID-CANCER, Annals of surgery, 227(6), 1998, pp. 912-918
Authors:
MYRICK D
BLACKINTON D
KLOSTERGAARD J
WANEBO H
MEHTA S
Citation: D. Myrick et al., TAXOL AND CERAMIDE ACT SYNERGISTICALLY IN THE GROWTH-INHIBITION OF JURKAT, A LEUKEMIC T-CELL LINE, The FASEB journal, 11(3), 1997, pp. 3157-3157
Authors:
CHOUGULE P
WANEBO H
AKERLEY W
MCRAE R
NIGRI P
LEONE L
SAFRAN H
READY N
KONESS RJ
RADIEKEANE K
COLE B
Citation: P. Chougule et al., CONCURRENT PACLITAXEL, CARBOPLATIN, AND RADIOTHERAPY IN ADVANCED HEADAND NECK CANCERS - A PHASE-II STUDY - PRELIMINARY-RESULTS, Seminars in oncology, 24(6), 1997, pp. 57-61
Authors:
WANEBO H
KENNEDY BJ
WINCHESTER DP
FREMGEN A
STEWART AK
Citation: H. Wanebo et al., GASTRIC-CARCINOMA - DOES LYMPH-NODE DISSECTION ALTER SURVIVAL, Journal of the American College of Surgeons, 183(6), 1996, pp. 616-624
Authors:
CLARK J
SIKOV W
CUMMINGS F
BROWN M
AKERLEY W
WANEBO H
WEITBERG A
KENNEDY T
COLE B
BIGLEY J
BEITZ J
DARNOWSKI J
Citation: J. Clark et al., PHASE-II STUDY OF 5-FLUORURACIL LEUCOVORIN AND AZIDOTHYMIDINE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Journal of cancer research and clinical oncology, 122(9), 1996, pp. 554-558
Citation: H. Cady B",reichner,"wanebo, INTERLEUKIN-6 PRODUCTION BY RAT HEPATOCELLULAR-CARCINOMA CELLS IS ASSOCIATED WITH METASTATIC POTENTIAL BUT NOT WITH TUMORIGENICITY - DISCUSSION, Archives of surgery, 131(4), 1996, pp. 364-365
Citation: H. Wanebo, MULTIMODALITY TREATMENT OF HEPATOCELLULAR-CARCINOMA IN A HEPATOBILIARY SPECIALTY CENTER - DISCUSSION, Archives of surgery, 131(3), 1996, pp. 298-298
Authors:
GLICKMAN AS
CLARK J
COACHMAN N
WANEBO H
KONESS J
DOOLITTLE C
DEROSA E
SLOTMAN G
POSNER M
Citation: As. Glickman et al., CONCURRENT CISPLATINUM AND RADIATION FOR ADVANCED HEAD AND NECK-CANCER - RESPONSE, International journal of radiation oncology, biology, physics, 31(3), 1995, pp. 681-681
Authors:
SHRAYER D
BOGAARS H
HEARING VJ
MAIZEL A
WANEBO H
Citation: D. Shrayer et al., FURTHER CHARACTERIZATION OF A CLINICALLY RELEVANT MODEL OF MELANOMA METASTASIS AND AN EFFECTIVE VACCINE, Cancer immunology and immunotherapy, 40(5), 1995, pp. 277-282
Authors:
AVRADOPOULOS D
BLACKINTON D
MEHTA S
WANEBO H
Citation: D. Avradopoulos et al., SERUM-DERIVED IMMUNOSUPPRESSIVE FACTOR(S) FROM PATIENTS WITH HEAD ANDNECK-CANCER, The FASEB journal, 8(5), 1994, pp. 10000751-10000751
Authors:
BLACKINTON D
MANFREDI M
CHAN O
GREEN S
MEHTA S
WANEBO H
Citation: D. Blackinton et al., INHIBITION OF NEOPLASTIC B-CELL GROWTH BY PLASMA-DERIVED HUMAN GLOBULIN FRACTIONS (NHG), The FASEB journal, 8(4), 1994, pp. 10000397-10000397
Authors:
CHAN O
BERG M
WANEBO H
CHERLIN D
POLK C
MEHTA S
Citation: O. Chan et al., LOW-FREQUENCY MAGNETIC-FIELD EFFECTS ON HUMAN B-CELL GROWTH AND DIFFERENTIATION, The FASEB journal, 8(4), 1994, pp. 10000399-10000399
Authors:
GLICKSMAN AS
SLOTMAN G
DOOLITTLE C
CLARK J
KONESS J
COACHMAN N
POSNER M
DEROSA E
WANEBO H
Citation: As. Glicksman et al., CONCURRENT CISPLATINUM AND RADIATION WITH OR WITHOUT SURGERY FOR ADVANCED HEAD AND NECK-CANCER, International journal of radiation oncology, biology, physics, 30(5), 1994, pp. 1043-1050
Authors:
SHRAYER D
BOGAARS H
GERSTEN D
HEARING V
MAIZEL A
WANEBO H
Citation: D. Shrayer et al., NUDE-MOUSE MODEL TO STUDY PASSIVE HUMORAL IMMUNOTHERAPY DIRECTED AGAINST B16-F10 MURINE MELANOMA, Journal of surgical oncology, 57(1), 1994, pp. 50-56